Quantitative Bioanalysis of Rituximab and Reditux for Biosimilarity Assessment: Comparing Triple Quadrupole and Hybrid Time-of-Flight Platforms

By: Richard Lavallée, Daniel Villeneuve, Kevork Mekhssian, Jean-Nicholas Mess and Anahita Keyhani.

Click on the link below to request this poster's reprint.